Simultaneous integrated boost technique by helical tomotherapy for the treatment of glioblastoma multiforme with 11C-methionine PET: report of three cases

J Neurooncol. 2008 May;87(3):333-9. doi: 10.1007/s11060-008-9519-3. Epub 2008 Jan 24.

Abstract

We performed hypofractionated high-dose irradiation of a patient's residual glioblastoma multiforme using a simultaneous integrated boost (SIB) technique with helical tomotherapy system (HT) planning. The gross tumor volume (GTV)-1 was defined as the area of intensive (11)C-methionine (MET) uptake and GTV-2 was defined as the area of moderate MET uptake. The planning target volume (PTV)-1 encompassed GTV-1 plus a 5 mm margin, and PTV-2 encompassed GTV-2 plus a 2 mm margin. SIB with HT was performed in eight fractions, planning the dose for GTV-1 at 68 Gy (biologically effective dose: BED = 126 Gy), PTV-1 at 56 Gy (BED = 95 Gy), and PTV-2 at 40 Gy (BED = 60 Gy). In each of the target areas, the uptake value on (11)C-methionine positron emission tomography (MET-PET) was considerably decreased following SIB, although no remarkable changes were demonstrated on magnetic resonance imaging (MRI). These cases demonstrate that SIB with HT planning using MET-PET offers excellent target coverage and uniformity. In addition, SIB with HT planning using MET-PET is organ sparing and MET-PET has great efficacy for monitoring treatment response after SIB. To more clearly define the impact of SIB with HT planning using MET-PET, further investigations are required.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aged
  • Brain Neoplasms / radiotherapy*
  • Carbon Radioisotopes
  • Female
  • Glioblastoma / radiotherapy*
  • Humans
  • Male
  • Methionine
  • Neoplasm, Residual
  • Neuronavigation*
  • Positron-Emission Tomography*
  • Radiotherapy Planning, Computer-Assisted / methods
  • Radiotherapy, Conformal / methods*
  • Tomography, Spiral Computed / methods*

Substances

  • Carbon Radioisotopes
  • Methionine